{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:04:01Z","timestamp":1785315841752,"version":"3.55.0"},"reference-count":36,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background\/Objectives: Fecal microbiota transplantation (FMT) is an established treatment for recurrent or refractory Clostridioides difficile infection (rCDI) and is increasingly investigated for other gastrointestinal and neuropsychiatric conditions in children. However, pediatric safety data remains limited. This study aimed to evaluate the short-term safety of colonoscopy-delivered FMT in a heterogeneous pediatric cohort. Methods: We conducted a retrospective single-centre cohort study of all FMT procedures performed at Vilnius University Hospital Santaros Klinikos between 2017 and 2025. Fecal material from three screened healthy pediatric donors was delivered to the caecum via colonoscopy under general anesthesia. Adverse events (AEs) arising within 72 h of each procedure were identified from the clinical records and assigned a severity grade using version 5.0 of the Common Terminology Criteria for Adverse Events (CTCAE). AEs were analyzed on a per-procedure basis. Associations between sex, age, and underlying indication and AE occurrence were assessed using Fisher\u2019s exact test and the Mann\u2013Whitney U test. Results: A total of 108 FMT procedures were performed on 73 children aged 2 to 17 years. The predominant indication was autism spectrum disorder (ASD) and other developmental disorders (80.6%). AEs were reported after 11 procedures (10.2%); all were classified as CTCAE grade 1 or 2, and no serious AEs occurred. The most common AEs were diarrhoea (5.6%) and vomiting (2.8%). In an exploratory comparison, procedures performed for ASD were associated with a lower AE rate compared with other indications combined (6.9% vs. 23.8%; OR 0.24, 95% CI 0.06\u20130.87). Conclusions: Colonoscopy-delivered FMT was well tolerated in pediatric patients, with a favorable short-term safety profile consistent with published pediatric FMT literature. As follow-up was largely passive and the cohort was predominantly children with ASD, the observed rate should be regarded as a lower bound, and these findings warrant confirmation in prospective studies.<\/jats:p>","DOI":"10.3390\/children13081005","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:16:52Z","timestamp":1785313012000},"page":"1005","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of Fecal Microbiota Transplantation in Children: A Single-Center Experience"],"prefix":"10.3390","volume":"13","author":[{"given":"Dominykas","family":"Varnas","sequence":"first","affiliation":[{"name":"Clinic of Children\u2019s Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-5484","authenticated-orcid":false,"given":"Vaidotas","family":"Urbonas","sequence":"additional","affiliation":[{"name":"Clinic of Children\u2019s Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm.4517","article-title":"Current Understanding of the Human Microbiome","volume":"24","author":"Gilbert","year":"2018","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2016.02.001","article-title":"Dysbiosis in Gastrointestinal Disorders","volume":"30","author":"Chang","year":"2016","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Acevedo-Rom\u00e1n, A., Pag\u00e1n-Zayas, N., Vel\u00e1zquez-Rivera, L.I., Torres-Ventura, A.C., and Godoy-Vitorino, F. (2024). Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179715"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20503121241257486","DOI":"10.1177\/20503121241257486","article-title":"Fecal Microbiota Transplantation and Next-Generation Therapies: A Review on Targeting Dysbiosis in Metabolic Disorders and Beyond","volume":"12","author":"Sahle","year":"2024","journal-title":"SAGE Open Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2413197","DOI":"10.1002\/advs.202413197","article-title":"Advances in Fecal Microbiota Transplantation for Gut Dysbiosis-Related Diseases","volume":"12","author":"Hou","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2015.05.008","article-title":"Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook","volume":"149","author":"Kelly","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1542\/peds.2009-3363","article-title":"Fecal Bacteriotherapy for Relapsing Clostridium difficile Infection in a Child: A Proposed Treatment Protocol","volume":"126","author":"Russell","year":"2010","journal-title":"Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPG.0000000000002205","article-title":"Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper from the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"68","author":"Davidovics","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000549227","article-title":"Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Where We Stand and What Is Next","volume":"10","author":"Ishikawa","year":"2025","journal-title":"Inflamm. Intest. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of Faecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome in a Randomised, Double-Blind, Placebo-Controlled Study","volume":"69","author":"Hatlebakk","year":"2020","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wang, K., Gao, C., Zhu, L., Chen, M., Tong, Y.X., and Zhang, S. (2025). Fecal Microbiota Transplantation for Chronic Constipation: A Systematic Review and Meta-Analysis of Clinical Efficacy, Safety, and Microbial Dynamics. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1604571"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska, E., Barszcz, E., Budny, E., Gajewska, A., Kope\u0107, K., Wasiak, J., Rysz, J., and Franczyk, B. (2025). The Gut\u2013Brain\u2013Microbiota Connection and Its Role in Autism Spectrum Disorders. Nutrients, 17.","DOI":"10.3390\/nu17071135"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102563","DOI":"10.1016\/j.eclinm.2024.102563","article-title":"Safety and Efficacy of Faecal Microbiota Transplantation in Patients with Mild to Moderate Parkinson\u2019s Disease (GUT-PARFECT): A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial","volume":"71","author":"Bruggeman","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40337-025-01276-0","article-title":"Investigating Fecal Microbiota Transplants from Individuals with Anorexia Nervosa in Antibiotic-Treated Mice Using a Cross-over Study Design","volume":"13","author":"Maschek","year":"2025","journal-title":"J. Eat. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41467-025-67267-6","article-title":"Encapsulated Faecal Microbiota Transfer in Young Women with Anorexia Nervosa: An Open-Label Feasibility Pilot Trial","volume":"17","author":"Wilson","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MPG.0000000000003229","article-title":"Updates and Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children","volume":"73","author":"Hourigan","year":"2021","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s12519-022-00655-w","article-title":"Fecal Microbiota Transplantation in Childhood: Past, Present, and Future","volume":"19","author":"Gu","year":"2023","journal-title":"World J. Pediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/apa.17167","article-title":"Faecal microbiota transplantation in children: A Systematic Review","volume":"113","author":"Lauwers","year":"2024","journal-title":"Acta Paediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.molmed.2023.12.005","article-title":"Dissecting Mechanisms of Fecal Microbiota Transplantation Efficacy in Disease","volume":"30","author":"Andary","year":"2024","journal-title":"Trends Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrgastro.2016.98","article-title":"Understanding the Mechanisms of Faecal Microbiota Transplantation","volume":"13","author":"Khoruts","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"17562848221134396","DOI":"10.1177\/17562848221134396","article-title":"The Role of the Gut Microbiome in Colonization Resistance and Recurrent Clostridioides difficile Infection","volume":"15","author":"Seekatz","year":"2022","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2393766","DOI":"10.1080\/19490976.2024.2393766","article-title":"Bile Acids Impact the Microbiota, Host, and C. difficile Dynamics Providing Insight into Mechanisms of Efficacy of FMTs and Microbiota-Focused Therapeutics","volume":"16","author":"McMillan","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Shin, Y., Han, S., Kwon, J., Ju, S., Choi, T., Kang, I., and Kim, S. (2023). Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease. Nutrients, 15.","DOI":"10.3390\/nu15204466"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-Chain Fatty Acids: Linking Diet, the Microbiome and Immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"107749","DOI":"10.1016\/j.phrs.2025.107749","article-title":"IUPHAR Review: Microbiota-Gut-Brain Axis and Its Role in Neuropsychiatric Disorders","volume":"216","author":"Lee","year":"2025","journal-title":"Pharmacol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"105840","DOI":"10.1016\/j.phrs.2021.105840","article-title":"The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders","volume":"172","author":"Doboszewska","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.scib.2025.01.029","article-title":"Fecal Microbiota Transplantation: Transitioning from Chaos and Controversial Realm to Scientific Precision Era","volume":"70","author":"Wang","year":"2025","journal-title":"Sci. Bull."},{"key":"ref_29","unstructured":"U.S. Department of Health and Human Services (2025, November 09). Common Terminology Criteria for Adverse Events (CTCAE), Available online: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/jgh.15996","article-title":"The Global Incidence of Adverse Events Associated with Fecal Microbiota Transplantation in Children over the Past 20 Years: A Systematic Review and Meta-analysis","volume":"37","author":"Wang","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Xiao, P., Li, Y., Li, X., Ge, T., Li, D., Xu, Q., Ruan, Y., Xiao, F., Xiao, Y., and Zhang, T. (2025). Long-Term Safety of Fecal Microbiota Transplantation in Chinese Children from 2013 to 2023: A Single-Center Retrospective Study. BMC Microbiol., 25.","DOI":"10.1186\/s12866-025-03858-z"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zou, B., Liu, S.-X., Li, X.-S., He, J.-Y., Dong, C., Ruan, M.-L., Xu, L., Bai, T., Huang, Z.-H., and Shu, S.-N. (2022). Long-Term Safety and Efficacy of Fecal Microbiota Transplantation in 74 Children: A Single-Center Retrospective Study. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.964154"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.2147\/NDT.S488001","article-title":"Fecal Microbiota Transplantation in Children with Autism","volume":"20","author":"Li","year":"2024","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Liber, A., and Wi\u0119ch, M. (2025). The Impact of Fecal Microbiota Transplantation on Gastrointestinal and Behavioral Symptoms in Children and Adolescents with Autism Spectrum Disorder: A Systematic Review. Nutrients, 17.","DOI":"10.3390\/nu17132250"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hsu, M., Tun, K.M., Batra, K., Haque, L., Vongsavath, T., and Hong, A.S. (2023). Safety and Efficacy of Fecal Microbiota Transplantation in Treatment of Inflammatory Bowel Disease in the Pediatric Population: A Systematic Review and Meta-Analysis. Microorganisms, 11.","DOI":"10.3390\/microorganisms11051272"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bieganska, E.A., Kosinski, P., and Wolski, M. (2025). Possible Applications of Fecal Microbiota Transplantation in the Pediatric Population: A Systematic Review. Biomedicines, 13.","DOI":"10.3390\/biomedicines13061393"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/8\/1005\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:47:34Z","timestamp":1785314854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/8\/1005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["children13081005"],"URL":"https:\/\/doi.org\/10.3390\/children13081005","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}